Search

Finance

Strategies and Pathways for Economic Viability for Scaling Health Innovations in Underserved Settings

As funding constraints reshape the global health landscape, innovators are facing an urgent question: how do they turn strong ideas and meaningful impact into a clear funding case that resonates with funders and investors? This question shaped a recent Innovation and Health Equity Discussion Series session, ‘Strategies and Pathways for Economic Viability for Scaling Health Innovations in Underserved Settings,’ hosted by Stanford Biodesign, in partnership with the Alliance and Baraka Impact Finance. James Bair, partner and managing director at Baraka Impact Finance, in conversation with Sara Anderson, executive director of the Alliance, offered practical guidance on how founders and innovators can position their ventures for funding, sustainability, and scale in a rapidly changing capital environment.

Another Month of Setbacks — and One Win — for US Public Health

A federal judge’s March 16 ruling temporarily blocking Robert F. Kennedy Jr.’s vaccine advisory overhaul offered a rare win for public health advocates — but it arrived against a backdrop of sustained institutional erosion. NIH grant awards are lagging far behind historical averages, the U.S. Preventive Services Task Force has not met in over a year, and CDC leadership has seen abrupt departures. Research budgets for cancer, Alzheimer’s, and mental health have been gutted. Read more in this March USG update.

Deep Dive with DFC’s Nafisa Jiwani & Monisha Ashok

Alliance Events, Virtual

The Alliance invites members to join us on Thursday, February 12, 2026 at 8 AM PT for a virtual deep dive session with Nafisa Jiwani, Associate Vice President of Health Initiatives at the U.S. Development Finance Corporation (DFC). This timely session on development financing and opportunities in global health will help participants understand how DFC capital works in practice, what types of health projects and business models are most competitive, which organizations might be eligible, and how to position opportunities to align with DFC’s investment priorities and processes.

JPM 2026 | From Products to Patients: Capturing Value in Asia and Africa’s Growth Markets

For the third consecutive year, the Alliance convened a panel at the 2026 J.P. Morgan Healthcare Conference (JPM) in San Francisco, followed by an Alliance side meeting held at Accenture’s San Francisco Innovation Hub. This year’s panel brought together leaders from Gilead Sciences, U.S. Development Finance Corporation (DFC), Nivi, Inc., reach52, and Accenture to explore how pharmaceutical partnerships, development finance, and patient platforms are creating investable infrastructure in high-growth markets across Asia and Africa. The panel underscored that the most promising long-term opportunities in emerging markets lie not just in individual products, but in the systems and partnerships that connect them to patients.

Women’s Health Is Vastly Underfunded. Here’s a Plan to Change That

BCG Read More

JPM 2026 | From Products to Patients: Capturing Value in Asia’s Growth Markets

Alliance Events, In-person

At the J.P. Morgan Healthcare Conference 2026, the Alliance will convene another strategic panel, From Products to Patients: Capturing Value in Asia’s Growth Markets, bringing together Gilead Sciences’ SVP of Emerging Markets, the head of U.S. DFC’s global health investments, and the CEOs of reach52 and Nivi, Inc. to explore how pharmaceutical partnerships, development finance, and patient platforms are creating investable infrastructure in high-growth markets across Asia. A post-JPM panel reception will follow, offering a continuation of the conversation and networking opportunities from 4:30-6:30pm PT.

Center of Excellence in Maternal, Child, & Adolescent Health Secures $1.8M Five-Year Federal Funding

UC Berkeley Read More

Big Aid is Over – What’s Next for Doers and Donors?

In-person

Co-hosted by the Network of Engaged International Donors (NEID Global) and Dalberg, join Kevin Starr, CEO of Mulago Foundation, and Ina Breuer, NEID Global Executive Director, on October 7 as they discuss strategies for scaling sustainable interventions in the post-‘Big Aid’ era.